Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer is a research paper published in JAMA Network Open (2024). On theSindex it has a DataRank of 0.562. It has been cited 14 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0.155
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
NIH HHS
Grant: OT2 OD032581
NCI NIH HHS
Grant: P30 CA006973
National Institutes of Health
Grant: 3OT2OD032581-01S6
AIM-AHEAD Coordinating Center - All Four Cores
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
Fields of Study
MeSH Terms
Keywords